One in four patients requiring hemodialysis will die from access failure.

One in four patients

At Ariste, we are developing a new class of drug eluting devices that will offer improved performance over legacy products. Our technology will help prevent device failure, resulting in improved patient outcomes and reduced costs of care.

See how Ariste technology works

Surgical infection continues to cause unnecessary morbidity and mortality.

Surgical Infection

At Ariste, we are developing a new class of drug eluting devices that will offer improved performance over legacy products. Our technology will help prevent device failure, resulting in improved patient outcomes and reduced costs of care.

See how Ariste technology works

Restenosis is a common cause of device failure.

Blood clot

At Ariste, we are developing a new class of drug eluting devices that will offer improved performance over legacy products. Our technology will help prevent device failure, resulting in improved patient outcomes and reduced costs of care.

See how Ariste technology works

Our Technology

Ariste has developed a novel method of eluting drugs from the surface of PTFE and ePTFE, the most slippery surface known.  Ariste’s technology will enable the development of a new class of drug-eluting devices that can improve outcomes in common vascular procedures, including hemodialysis access, peripheral bypass and hernia repair.

Ariste is presently developing a drug-eluting vascular graft for hemodialysis access and a drug-eluting tissue patch for hernia repair. Why is this important? Because PTFE, better known as Teflon, and ePTFE, better known as GoreTex, have been preferred materials for medical implants since the 1970...

More >

Latest News

Ariste Medical Receives Issued U.S. Patent and Raises Seed Capital

MEMPHIS, Tenn. (October 29, 2012) – Ariste Medical, Inc., announced today that a key patent has been issued by the United States Patent and Trademark Office (USPTO). The U.S. patent (#8,236,338) covers a formulation capable of coating polytetrafluoroethylene (PTFE) and expanded PTFE, more commonly known as Teflon® and Gore-Tex®, respectively.  The novel coating is capable of incorporating multiple pharmaceutical agents, enabling surgically implantable medical devices made from PTFE or ePTFE to also be used as drug-delivery devices.  Ariste is presently developing a drug-eluting vascular graft for the prevention of re…

More >

Contact Us

Find out more about how Ariste Medical's technology can impact your product and bottom line.